What I'm saying is why not have one meeting on prescription drugs to see if that entices us more as an issue we'd want to investigate. But I'm pointing out to the chair that there's a third subject for a possible long-term study that we're not having a meeting on. Maybe if there's a meeting left, if we don't rise too early, we could get a few people in to talk to us about why that's such an important subject.
On May 16th, 2006. See this statement in context.